Different treatment of grade 1 endometrial cancer seems to have no effect on the survival rate.
Endrocrine-disrupting chemicals (EDCs-natural or synthetic compounds that interfere with hormone biosynthesis or metabolism and alter homeostatic control or reproduction-are a significant concern to public health, according to the first scientific statement on the subject issued by the Endocrine Society.
Representing a broad class of molecules, such as organochlorinated pesticides and industrial chemicals, plastics and plasticizers, fuels, and many other chemicals present in the environment and in widespread use, EDCs have wide-ranging effects on male and female reproduction, breast development and cancer, prostate cancer, neuroendocrinology, thyroid function, metabolism and obesity, and cardiovascular endocrinology. Pathways of disruption involve, but are not limited to, estrogenic, antiandrogenic, thyroid, peroxisome proliferator-activated receptor γ, retinoid, and actions through other nuclear receptors; steroidogenic enzymes; and neurotransmitter receptors and systems.
The statement explains that the most important determinants of endocrine disruption are age at exposure; the time between exposure and the manifestation of a disorder; the mixture of chemicals to which an individual is exposed; nontraditional dose-response dynamics (e.g., that sometimes low doses exert more potent effects than higher doses); and long-term latent effects (e.g., affecting subsequent generations).
Diamanti-Kandarakis E, Bourguignon JP, Guidice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293-342.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More